• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort.瑞士炎症性肠病队列中克罗恩病患者发生瘘管和狭窄的危险因素
Inflamm Intest Dis. 2017 Apr;1(4):172-181. doi: 10.1159/000458144. Epub 2017 Feb 25.
2
Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.韩国肛周瘘与克罗恩病临床特征及预后的相关性:CONNECT 研究结果。
Gut Liver. 2018 Sep 15;12(5):544-554. doi: 10.5009/gnl18157.
3
Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort.基于人群的队列研究中肛周克罗恩病的临床和遗传风险因素。
Am J Gastroenterol. 2012 Apr;107(4):589-96. doi: 10.1038/ajg.2011.437. Epub 2011 Dec 13.
4
Perianal fistulae following infliximab treatment: clinical and endosonographic outcome.英夫利昔单抗治疗后肛周瘘管:临床及超声内镜检查结果
Inflamm Bowel Dis. 2004 Mar;10(2):91-6. doi: 10.1097/00054725-200403000-00005.
5
Perianal magnetic resonance imaging findings and their potential impact on outcome in children with perianal fistulizing Crohn disease.肛周磁共振成像的表现及其对肛周瘘管型克罗恩病患儿结局的潜在影响。
Pediatr Radiol. 2021 Dec;51(13):2481-2491. doi: 10.1007/s00247-021-05158-w. Epub 2021 Sep 6.
6
Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.基于人群队列的肛周瘘管型克罗恩病的流行病学及转归的时间趋势
Eur J Gastroenterol Hepatol. 2017 May;29(5):595-601. doi: 10.1097/MEG.0000000000000840.
7
Clinical and Radiologic Characteristics of Intra-Abdominal Fistulizing Crohn's Disease.腹腔内瘘管形成的克罗恩病的临床和放射学特征。
Digestion. 2020;101(6):667-673. doi: 10.1159/000501514. Epub 2019 Jul 10.
8
Elicitation of Health-Related Utility in Perianal Fistula in Crohn's Disease.诱导健康相关效用在克罗恩病肛周瘘管中。
Patient. 2019 Jun;12(3):339-348. doi: 10.1007/s40271-018-0352-2.
9
Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.CARD15移码突变1007fs的纯合性预示着克罗恩病早期发作,伴有回肠狭窄、肠-肠瘘,且频繁需要手术干预,再狭窄风险高。
Scand J Gastroenterol. 2006 Dec;41(12):1421-32. doi: 10.1080/00365520600703900.
10
Perianal fistulodesis - A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulae.肛周瘘管固定术——一种用于闭合肛周瘘管的新型微创外科及药物治疗方法的初步研究
World J Gastrointest Surg. 2021 Feb 27;13(2):187-197. doi: 10.4240/wjgs.v13.i2.187.

引用本文的文献

1
Epidemiology, treatment patterns, and associated risk factors in perianal fistulizing Crohn's disease: A systematic literature review.肛周瘘管性克罗恩病的流行病学、治疗模式及相关危险因素:一项系统文献综述
World J Gastrointest Surg. 2025 Jul 27;17(7):101767. doi: 10.4240/wjgs.v17.i7.101767.
2
The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn's Disease.肥胖对克罗恩病肛周瘘管患病率及并发症的影响
Dig Dis Sci. 2025 Jan;70(1):323-332. doi: 10.1007/s10620-024-08729-7. Epub 2024 Nov 16.
3
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.克罗恩病的表型及其与合并症、手术风险、药物治疗和非药物治疗方法的关联:IMAGINE研究中的MAGIC研究
Inflamm Bowel Dis. 2025 Jan 6;31(1):113-122. doi: 10.1093/ibd/izae055.
4
Ferric carboxymaltose for anemia in Crohn's disease patients at a tertiary center: A retrospective observational cohort study.三级中心使用羧基麦芽糖铁治疗克罗恩病患者贫血:一项回顾性观察队列研究。
World J Clin Cases. 2023 Apr 26;11(12):2740-2752. doi: 10.12998/wjcc.v11.i12.2740.
5
Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn's disease.在有瘘管型克罗恩病且曾使用过抗TNF药物的患者中,维多珠单抗比优特克单抗更有可能停药。
Therap Adv Gastroenterol. 2023 Mar 3;16:17562848221148254. doi: 10.1177/17562848221148254. eCollection 2023.
6
Crohn's Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities.克罗恩病相关性瘘管和隐窝腺性瘘管:差异与相似之处
J Clin Med. 2023 Jan 6;12(2):466. doi: 10.3390/jcm12020466.
7
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis study.炎症和组织重塑在克罗恩病狭窄纤维化形成中起作用:图像处理与分析研究
J Pathol Transl Med. 2022 Sep;56(5):239-248. doi: 10.4132/jptm.2022.05.18. Epub 2022 Jul 4.
8
Crohn's strictures open with anti-mycobacterial antibiotic therapy: A retrospective review.克罗恩狭窄经抗分枝杆菌抗生素治疗后开放:一项回顾性研究。
World J Gastrointest Endosc. 2020 Dec 16;12(12):542-554. doi: 10.4253/wjge.v12.i12.542.
9
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort.遗传风险因素可预测瑞士炎症性肠病队列中克罗恩病患者的疾病进展。
Therap Adv Gastroenterol. 2020 Nov 19;13:1756284820959252. doi: 10.1177/1756284820959252. eCollection 2020.
10
Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.英夫利昔单抗对中国肛周瘘管型克罗恩病患者深部放射学缓解的疗效。
Dig Dis Sci. 2021 May;66(5):1658-1668. doi: 10.1007/s10620-020-06398-w. Epub 2020 Jun 10.

本文引用的文献

1
Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病诊断延迟的系统评价
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):245-247. doi: 10.1097/MPG.0000000000001238.
2
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.早期联合免疫抑制治疗克罗恩病的效果(REACT):一项集群随机对照试验。
Lancet. 2015 Nov 7;386(10006):1825-34. doi: 10.1016/S0140-6736(15)00068-9. Epub 2015 Sep 3.
3
Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?早期抗 TNF 治疗对 IBD 并发症的益处?
J Crohns Colitis. 2015 Nov;9(11):997-1003. doi: 10.1093/ecco-jcc/jjv130. Epub 2015 Jul 29.
4
Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery.日本克罗恩病的长期病程:并发症发生率、初次手术累积率及诊断时初次手术的危险因素。
J Gastroenterol Hepatol. 2015 Dec;30(12):1713-9. doi: 10.1111/jgh.13013.
5
Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn's Disease.根据莱曼指数评估的肠道损伤在克罗恩病的抗TNF治疗中是可逆的。
J Crohns Colitis. 2015 Aug;9(8):633-9. doi: 10.1093/ecco-jcc/jjv080. Epub 2015 May 9.
6
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.磁共振成像对克罗恩病病变中炎症和纤维化的特征描述。
Am J Gastroenterol. 2015 Mar;110(3):432-40. doi: 10.1038/ajg.2014.424. Epub 2015 Jan 27.
7
Crohn's disease management after intestinal resection: a randomised trial.肠切除术后克罗恩病的管理:一项随机试验。
Lancet. 2015 Apr 11;385(9976):1406-17. doi: 10.1016/S0140-6736(14)61908-5. Epub 2014 Dec 24.
8
Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature.炎症性肠病复发和再发中的环境因素:文献综述
Dig Dis Sci. 2015 May;60(5):1396-405. doi: 10.1007/s10620-014-3437-3. Epub 2014 Nov 19.
9
The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.硫唑嘌呤治疗时机和持续时间对克罗恩病首次肠道切除术的影响:1989-2010 年英国全国基于人群的研究。
Am J Gastroenterol. 2014 Mar;109(3):409-16. doi: 10.1038/ajg.2013.462. Epub 2014 Jan 28.
10
The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae.Dickkopf-1同源物在克罗恩病相关瘘管发病机制中的作用。
PLoS One. 2013 Nov 8;8(11):e78882. doi: 10.1371/journal.pone.0078882. eCollection 2013.

瑞士炎症性肠病队列中克罗恩病患者发生瘘管和狭窄的危险因素

Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort.

作者信息

Zeitz Jonas, Fournier Nicolas, Labenz Christian, Biedermann Luc, Frei Pascal, Misselwitz Benjamin, Scharl Sylvie, Vavricka Stephan R, Sulz Michael C, Fried Michael, Rogler Gerhard, Scharl Michael

机构信息

Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Institute of Social and Preventive Medicine, Université de Lausanne, Lausanne, Switzerland.

出版信息

Inflamm Intest Dis. 2017 Apr;1(4):172-181. doi: 10.1159/000458144. Epub 2017 Feb 25.

DOI:10.1159/000458144
PMID:29922674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5988106/
Abstract

BACKGROUND

Fistulae and stenoses represent frequent and severe complications in patients with Crohn disease (CD). Our study aimed to identify risk factors for fistula and stenosis formation in CD patients.

SUMMARY

We retrieved data of 1,600 CD patients from the nationwide Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). The risk for fistulae and stenoses in relation to gender, age at diagnosis, smoking status at diagnosis, and ileal involvement at diagnosis were analyzed. In the multivariate analysis, female gender showed a lower risk for developing perianal and any fistula (risk ratio [RR] 0.721, 95% confidence interval [CI] 0.582-0.893, = 0.003 and RR 0.717, 95% CI 0.580-0.888, = 0.002, respectively), and older age at diagnosis showed a lower risk for developing perianal fistula (RR 0.661, 95% CI 0.439-0.995, = 0.047). Furthermore, ileal involvement was associated with a lower risk for perianal fistula (RR 0.713, 95% CI 0.561-0.906, = 0.006), a lower risk for any fistula (RR 0.709, 95% CI 0.558-0.901, = 0.005), and a higher risk for stenosis (RR 2.170, 95% CI 1.728-2.725, < 0.001).

KEY MESSAGES

In the nationwide SIBDCS, younger age at diagnosis and male gender were risk factors for developing perianal and nonperianal fistulae. Additionally, ileal involvement was revealed to be a potent risk factor (RR 2.170) for developing a stenosis.

摘要

背景

瘘管和狭窄是克罗恩病(CD)患者常见且严重的并发症。我们的研究旨在确定CD患者发生瘘管和狭窄的风险因素。

总结

我们从全国性的瑞士炎症性肠病队列研究(SIBDCS)中检索了1600例CD患者的数据。分析了与性别、诊断时年龄、诊断时吸烟状况以及诊断时回肠受累情况相关的发生瘘管和狭窄的风险。在多变量分析中,女性发生肛周瘘管和任何瘘管的风险较低(风险比[RR]分别为0.721,95%置信区间[CI]为0.582 - 0.893,P = 0.003;RR为0.717,95% CI为0.580 - 0.888,P = 0.002),诊断时年龄较大发生肛周瘘管的风险较低(RR为0.661,95% CI为0.439 - 0.995,P = 0.047)。此外,回肠受累与肛周瘘管风险较低(RR为0.713,95% CI为0.561 - 0.906,P = 0.006)、任何瘘管风险较低(RR为0.709,95% CI为0.558 - 0.901,P = 0.005)以及狭窄风险较高(RR为2.170,95% CI为1.728 - 2.725,P < 0.001)相关。

关键信息

在全国性的SIBDCS中,诊断时年龄较小和男性是发生肛周和非肛周瘘管的风险因素。此外,回肠受累被发现是发生狭窄的一个重要风险因素(RR为2.170)。